Physician profile
Ruth E Tedaldi
NPI 1518923663
$145,181.82
in general payments reported to CMS, 2019-2025
11 companies · $38K in 2025
The $38K reported for 2025 was more than what 95% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $36K · 2021: $13K · 2022: $8,748 · 2023: $10K · 2024: $1,061 · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44K · Food and Beverage: $2,796 · Consulting Fee: $2,400 · Travel and Lodging: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $43,500.00 |
| Food and Beverage | $2,795.99 |
| Consulting Fee | $2,400.00 |
| Travel and Lodging | $445.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $89,072.21 | 2019-2022 | |
| Revance Therapeutics, INC. | $38,678.66 | 2024-2025 | Daxxify, Daxi |
| Abbvie INC. | $9,295.36 | 2021-2025 | Botox |
| Merz North America, INC. | $7,608.98 | 2019-2024 | Xeomin |
| Galderma Laboratories, L.P. | $130.08 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $122.82 | 2021-2025 | |
| Lilly USA, LLC | $85.22 | 2022-2024 | Olumiant, Taltz, Ebglyss |
| Aclaris Therapeutics, INC. | $64.12 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $57.19 | 2023-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $38.65 | 2023 | |
| Incyte Corporation | $28.53 | 2023 | Opzelura |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Tedaldi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.